Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis

Abstract

Intraluminally injected MSC spheroids at least partially attenuate experimental colitis, with fewer phagocytes and proinflammmatory cytokines, when a high dose of MSCs in spheroids was administered.

Experimental colitismesenchymal stromal cellspheroid